Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: The acidic microenvironment promotes pancreatic cancer progression via the lncRNA-LOC100507424/E2F1/FOXM1 axis

Fig. 5

LOC100507424 interacts with E2F1. A: catRAPID prediction of LOC100507424 binding to E2F1. B: Silver staining image from RNA pull-down assay. C: Western blot analysis of RNA pull-down products. D: Electropherogram from RIP assay. E: Enrichment analysis of RIP products. F: GEPIA analysis showing the correlation between E2F1 and FOXM1. G-H: Validation of transfection efficiency. I: ChIP analysis of E2F1 binding to the FOXM1 promoter in sicon vs. siLOC100507424 cells

Back to article page